News
For example, biotech and... NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback